期刊文献+

肝门胆管癌预后因素69例临床分析 被引量:3

原文传递
导出
摘要 目的探讨影响肝门胆管癌预后的因素及其治疗方法。方法回顾性分析69例肝门胆管癌患者的临床组织病理学特点、手术方法及随访资料。结果高分化腺癌21例(32.8%),中位生存期26.4个月;中、低分化腺癌43例(67.2%),中位生存期9.5个月;二者差异有统计学意义(P<0.01)。按TNM分期,Ⅰ、Ⅱ期39例中位生存期24.2个月,Ⅲ、Ⅳ期30例中位生存期11.5月(P=0.033);根治性切除46例中位生存期21.5个月,高于姑息性切除23例中位生存期(8.3个月,P=0.017)。结论肿瘤分化程度、临床分期、手术方式是影响肝门胆管癌预后的重要因素,加强围手术期处理,选择性地进行根治性切除或姑息性手术,是治疗肝门胆管癌的正确方法。
出处 《中国综合临床》 北大核心 2007年第7期632-633,共2页 Clinical Medicine of China
  • 相关文献

参考文献9

二级参考文献26

  • 1卢晓明,周友生,陈道达.第Ⅲ段肝管空肠吻合治疗肝门部胆管恶性梗阻(附28例报告)[J].中国实用外科杂志,1995,15(12):743-744. 被引量:4
  • 2黄志强.黄志强胆道外科[M].济南:山东科学技术出版社,1995.799-803.
  • 3Seiji K,Hiroshi I,Akira K,et al.Results of surgical resection for patients with hilar bile duct cancer[J].Ann Surg,2003,238(1):84-92.
  • 4Kondo S,Hirano S,Ambo Y,et al.Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins[J].Ann Surg,2004,240(1):95-101.
  • 5Ogura Y,Kawarada Y.Surgical strategies for carcinoma of the hepatic duct confluence[J].Br J Surg,1998,85(1):20-24.
  • 6Kosuge T,Yamamoto J,Shimada K,et al.Improved surgical resultsfor hilar cholangiocarcinoma with procedures including major hepaticresection.Ann Surg,1999,230(5):663-671.
  • 7Tojima Y,Nagino M,Ebata T,et al.Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholaniocarcinoma[J].Ann Surg,2003,237(2):201-207.
  • 8Klempnauer J,Ridder G J,Werner M,et al.What constitutes long term survival after surgery for hilar cholangiocarcinoma[J]? Cancer,1997,79(1):26-34.
  • 9Kitagawa Y,Nagino M,Kamiya J,et al.Lymph node metastasis from hilar cholangiocarcinoma:audit of 110 patients hho underwent regional and paraaortic node dissection[J].Ann Surg,2001,233(3):385-392.
  • 10Shimada M,Yamashita Y,Aishima S,et al.Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma[J].Br J Surg,2001,88:1463-1466.

共引文献78

同被引文献21

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部